Ventas (NYSE:VTR - Get Free Report) released its quarterly earnings results on Tuesday. The real estate investment trust reported $0.99 earnings per share for the quarter, beating the consensus estimate of $0.16 by $0.83, Zacks reports. The company had revenue of $1.82 billion during the quarter, compared to analysts' expectations of $1.77 billion. Ventas had a net margin of 4.08% and a return on equity of 1.99%.
Ventas Stock Down 4.8%
NYSE:VTR traded down $4.20 on Tuesday, hitting $83.22. 5,397,959 shares of the company's stock were exchanged, compared to its average volume of 3,632,285. The firm has a 50-day moving average price of $87.91 and a 200-day moving average price of $86.22. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.44 and a quick ratio of 0.44. Ventas has a 52 week low of $68.15 and a 52 week high of $101.60. The company has a market cap of $42.69 billion, a P/E ratio of 154.12, a price-to-earnings-growth ratio of 3.39 and a beta of 0.72.
Ventas Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Thursday, October 15th. Shareholders of record on Wednesday, September 30th were paid a $0.52 dividend. This represents a $2.08 annualized dividend and a yield of 2.5%. The ex-dividend date was Wednesday, September 30th. Ventas's payout ratio is presently 385.19%.
Analyst Ratings Changes
Several equities research analysts recently commented on VTR shares. Royal Bank Of Canada boosted their price objective on shares of Ventas from $98.00 to $99.00 and gave the company an "outperform" rating in a research report on Friday, August 14th. The Goldman Sachs Group increased their target price on Ventas from $110.00 to $114.00 and gave the stock a "buy" rating in a report on Friday, July 24th. Evercore set a $100.00 target price on Ventas and gave the stock an "outperform" rating in a report on Monday, September 21st. Scotiabank lifted their price target on Ventas from $93.00 to $95.00 and gave the company a "sector perform" rating in a research note on Wednesday, September 2nd. Finally, Citigroup boosted their price target on Ventas from $100.00 to $110.00 and gave the company a "buy" rating in a report on Tuesday, August 4th. Eighteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. Based on data from MarketBeat, Ventas currently has an average rating of "Moderate Buy" and a consensus price target of $98.91.
Get Our Latest Stock Analysis on Ventas
About Ventas
(
Get Free Report)
Ventas, Inc NYSE: VTR is a real estate investment trust focused on healthcare and senior housing properties. The company owns, manages and develops a diversified portfolio of healthcare-related real estate, including senior living communities, medical office buildings, life science and innovation centers, and other properties serving healthcare providers and institutions.
Ventas generally leases its properties to healthcare operators, physicians, health systems, universities and research organizations.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ventas, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ventas wasn't on the list.
While Ventas currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.